Gushengtang Holdings Ltd
HKEX:2273
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
33.25
51.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gushengtang Holdings Ltd
Total Receivables
Gushengtang Holdings Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Total Receivables
ÂĄ181.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Receivables
ÂĄ5.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
Topchoice Medical Co Inc
SSE:600763
|
Total Receivables
ÂĄ238.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
32%
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Receivables
ÂĄ1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
35%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Receivables
ÂĄ9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
37%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Receivables
ÂĄ3.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
50%
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.
See Also
What is Gushengtang Holdings Ltd's Total Receivables?
Total Receivables
181.6m
CNY
Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Total Receivables amounts to 181.6m CNY.
What is Gushengtang Holdings Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
18%
Over the last year, the Total Receivables growth was 103%. The average annual Total Receivables growth rates for Gushengtang Holdings Ltd have been 22% over the past three years , 18% over the past five years .